AbbVie Partnering Day in Toronto
Toronto | September 26, 2024
AbbVie, in collaboration with OBIO®, will host a Partnering Day in Toronto, bringing together researchers, entrepreneurs and biotech companies from Canada on September 26, 2024.
Note: This is a private event. All attendees will need to be pre-approved by the AbbVie team.
Agenda:
Morning: One-on-one partnering meetings with pre-selected companies
See instructions for meeting requests below.
Afternoon: AbbVie Showcase
Overview of AbbVie’s strategies and external innovation priorities
AbbVie’s approach to partnering
Networking reception
Participants must register in advance and be approved to attend the AbbVie Showcase.
One-on-one Partnering Meeting
Companies must apply in advance and be approved for a one-on-one partnering meeting. Please send a meeting request to partneringday@abbvie.com.
Selection Criteria
One-on-one meeting proposals will be evaluated by a panel of AbbVie reviewers by the following criteria:
Projects in all stages from discovery to clinical stage in our Areas of Interest
Strategic fit and differentiation from existing solutions
Deadline to submit applications: September 6, 2024
Limited seats for one-on-one meetings available.
AbbVie Delegates:
Niels Emmerich, VP, Global Head S&E and Alliances
Arpita Maiti, Head of S&E Immunology
Jenny Wang, Director, S&E Oncology
Murali Gopalakrishnan, Senior Director, S&E Neuroscience
Doug Faunce, Executive Director, Head of S&E Eye Care
Chinmay Kanuga, Senior Director, S&E Medical Aesthetics
Jay Stamatis, VP, BD&A
Christian Schubert, VP, AbbVie Ventures
FAQs
-
Please do not submit any confidential information as any submitted information be treated as non-confidential. Of course, we (AbbVie) will use this information only internally for evaluation purposes and will not further distribute.
-
You will have the opportunity and are encouraged to share supporting nonconfidential materials such as slide decks, research papers as part of your application.
-
No, a patent is not required to apply. However, you should not submit any information that you wish to keep confidential or that may negatively impact upon the future patentability of your invention.
-
Depending on the type and stage of development of the opportunity (from discovery to clinical) we have flexible partnership models (e.g. research collaborations, licensing and direct investments)